Tumor hypoxia and hypoxic markers in non-small cell lung cancer

Permanent link
https://hdl.handle.net/10037/6796
Thumbnail
View/Open
Thesis introduction (PDF)
Eilertsen M, Andersen S, Al-Saad S, Kiselev Y, Donnem T, Stenvold H, Pettersen I, Khalid Al-Shibli, Richardsen E, Busund LT, Bremnes RM: 'Monocarboxylate transporters 1-4 in NSCLC: MCT1 is an independent prognostic marker for survival', submitted manuscript. Later published in PLOS One, September 2014, Volume 9 Issue 9, e105038 (PDF)
Date
2014-03-14
Type
Doctoral thesis
Doktorgradsavhandling

Author
Eilertsen, Marte
Description
Papers number 1, 2 and 4 of this thesis are not available in Munin due to publishers' restrictions:
1. Andersen S, Eilertsen M, Donnem T, Al Shibli K, Al-Saad S, Busund LT, Bremnes RM: 'Diverging prognostic impacts of hypoxic markers according to NSCLC histology', Lung Cancer (2011), 72, 294-302, available at http://dx.doi.org/10.1016/j.lungcan.2010.10.006
2. Eilertsen M, Pettersen I, Andersen S, Martinez I, Donnem T, Busund LT, Bremnes RM: 'In NSCLC, VEGF-A response to hypoxia may differ between squamous cell and adenocarcinoma histology', Anticancer Research (2012), 32, 4729-36.
4. Eilertsen M, Andersen S, Al-Saad S, Richardsen E, Stenvold H, Hald SM, Al-Shibli K, Donnem T, Busund LT, Bremnes RM: 'Positive prognostic impact of miR-210 in non-small cell lung cancer', Lung Cancer Volume 83, Issue 2, February 2014, Pages 272–278, available at http://dx.doi.org/10.1016/j.lungcan.2013.11.005
Publisher
UiT The Arctic University of Norway
UiT Norges arktiske universitet
Metadata
Show full item record
Collections
Copyright 2014 The Author(s)

The following license file are associated with this item:

Attribution-NonCommercial-ShareAlike 3.0 Unported (CC BY-NC-SA 3.0)
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 3.0 Unported (CC BY-NC-SA 3.0)